Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 27 August 2009, Vol. 114, No. 9, pp. 1831-1841.
Prepublished online as a Blood First Edition Paper on July 7, 2009; DOI 10.1182/blood-2008-11-187419.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Results and Figure
Right arrow All Versions of this Article:
blood-2008-11-187419v1
114/9/1831    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Usenko, T.
Right arrow Articles by Ben-David, Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Usenko, T.
Right arrow Articles by Ben-David, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted November 3, 2008
Accepted May 29, 2009

Enrichment of SCA1 positive hematopoietic progenitors in polycythemic mice inhibits leukemogenesis

Tatiana Usenko, You-Jun Li, Mehran Haeri, Yanmei Li, Laura M. Vecchiarelli-Federico, Xiaojun Zhao, Josef T Prchal, and Yaacov Ben-David*

Molecular and Cellular Biology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada
Division of Hematology, University of Utah School of Medicine, Salt Lake City, UT, United States

* Corresponding author; email: bendavid{at}sri.utoronto.ca.

Polycythemia vera (PV) is a myeloproliferative disorder characterized by a pronounced increase in the number of erythroid cells. However, despite this aberrant proliferation, the incidence of erythroleukemia is paradoxically rare in PV patients. In this study, we show that the progression of Friend virus-induced erythroleukemia is delayed in a mouse model of primary familial congenital polycythemia (PFCP) in which the wild-type Epo-receptor (EpoR) gene is replaced with a truncated human EPOR gene. Herein, we show that these mice exhibit enrichment of Sca1+/cKit- progenitors and several mature immune cells such as dendritic cells and macrophages. In co-transplantation experiments, Sca1+/cKit- progenitors inhibit the tumorigenicity of Sca1-/cKit+ erythroleukemic cells. A cell line established from Sca1+/cKit- progenitors is also capable of inhibiting leukemic proliferation in culture and in mice. This phenomenon of leukemic inhibition, also detected in the serum of PV patients, is partially attributed to increased nitric oxide (NO) secretion. In addition, the administration of erythropoietin into leukemic mice induces a polycythemia-like state associated with the expansion of Sca1+/cKit- progenitors and derivative immune cells thereby inhibiting leukemia progression. This study indicates that a combination therapy incorporating the enrichment of Sca1+/cKit- progenitors may serve as a novel approach for the treatment of leukemia.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020